Zdrowie i gospodarka · 19/12/2018
FDA Announces Final Guidance for Breakthrough Devices Program
The Food and Drug Administration (FDA) has released the final guidance for the Breakthrough Devices Program, which combines elements from the Expedited Access Pathway and Priority Review Program to expedite the review of medical devices addressing unmet medical needs.
Source: Federal Register — Food and Drug AdministrationOpen original release →